Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation ; volume:20 ; number:1 ; day:28 ; month:4 ; year:2016 ; pages:1-15 ; date:12.2016
Critical care ; 20, Heft 1 (28.4.2016), 1-15, 12.2016
- Creator
- Contributor
-
Aisenberg, James
Bernstein, Richard
Goldstein, Patrick
Huisman, Menno V.
Jamieson, Dara G.
Levy, Jerrold
Pollack, Charles V.
Spyropoulos, Alex C.
Steiner, Thorsten
Del Zoppo, Gregory J.
Eikelboom, John
SpringerLink (Online service)
- DOI
-
10.1186/s13054-016-1275-8
- URN
-
urn:nbn:de:1111-201604301551
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Grottke, Oliver
- Aisenberg, James
- Bernstein, Richard
- Goldstein, Patrick
- Huisman, Menno V.
- Jamieson, Dara G.
- Levy, Jerrold
- Pollack, Charles V.
- Spyropoulos, Alex C.
- Steiner, Thorsten
- Del Zoppo, Gregory J.
- Eikelboom, John
- SpringerLink (Online service)
Other Objects (12)
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal
Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model
Factor VIII Inhibitors: Therapeutic Response to Prothrombin Complex Concentrates
The effects between andexanet alpha and four-factor prothrombin complex concentrate on DOACs anticoagulation reversal
Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report
Thrombogenic Characteristics of Activated and Standard Concentrates of Prothrombin Complex
Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
Recent Reduction in Thrombogenic Enzyme Content of Prothrombin Complex Concentrates
Reversal of rivaroxaban anticoagulant effect by prothrombin complex concentrates: which dose is sufficient to restore normal thrombin generation?
Idarucizumab: A novel antidote for reversal of dabigatran
Andexanet alpha versus four-factor prothrombin complex concentrate in DOACs anticoagulation reversal: an updated systematic review and meta-analysis
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal
Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model
Factor VIII Inhibitors: Therapeutic Response to Prothrombin Complex Concentrates
The effects between andexanet alpha and four-factor prothrombin complex concentrate on DOACs anticoagulation reversal
Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report
Thrombogenic Characteristics of Activated and Standard Concentrates of Prothrombin Complex
Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
Recent Reduction in Thrombogenic Enzyme Content of Prothrombin Complex Concentrates
Reversal of rivaroxaban anticoagulant effect by prothrombin complex concentrates: which dose is sufficient to restore normal thrombin generation?
Idarucizumab: A novel antidote for reversal of dabigatran
Andexanet alpha versus four-factor prothrombin complex concentrate in DOACs anticoagulation reversal: an updated systematic review and meta-analysis
Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation
A French multicenter randomised trial comparing two dose-regimens of prothrombin complex concentrates in urgent anticoagulation reversal
Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model
Factor VIII Inhibitors: Therapeutic Response to Prothrombin Complex Concentrates
The effects between andexanet alpha and four-factor prothrombin complex concentrate on DOACs anticoagulation reversal
Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report
Thrombogenic Characteristics of Activated and Standard Concentrates of Prothrombin Complex
Clinical review: Prothrombin complex concentrates - evaluation of safety and thrombogenicity
Recent Reduction in Thrombogenic Enzyme Content of Prothrombin Complex Concentrates
Reversal of rivaroxaban anticoagulant effect by prothrombin complex concentrates: which dose is sufficient to restore normal thrombin generation?
Idarucizumab: A novel antidote for reversal of dabigatran